Consistent with previous findings, POLR3G expression is commonly associated with unfavorable outcomes, most notably in clear cell renal cell carcinoma (KIRC) and brain lower-grade glioma (LGG). The gene discussed is POLR3G; the disease is clear cell renal carcinoma.